YM155, a novel small molecule survivin suppressant, exhibits curative antitumor activities in experimental human malignant lymphoma models in vivo

被引：1
作者：
Kita, A.
Nakahara, T.
Yamanaka, K.
Koutoku, H.
Takeuchi, M.
Kinoyama, I.
Matsuhisa, A.
Sasamata, M.
机构：
[1] Astellas Pharma Inc, Pharmacol Res Labs, Tsukuba, Ibaraki, Japan
[2] Astellas Pharma Inc, Mol Med Res Labs, Tsukuba, Ibaraki, Japan
[3] Astellas Pharma Inc, Chem Res Labs, Tsukuba, Ibaraki, Japan
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70382-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
377
引用
收藏
页码：116 / 116
页数：1
相关论文
共 46 条
  • [21] Antitumor activity of YM 155, a novel survivin suppressant, in combination with docetaxel against malignant melanoma cells.
    Kaneko, N.
    Yamanaka, K.
    Kita, A.
    Nakata, M.
    Koutoku, H.
    Sasamata, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Broad spectrum and potent anti tumor activity of YM155, a novel small molecule survivin suppressant, against a large scale panel of human tumor cell lines
    Nakahara, T.
    Takeuchi, M.
    Kita, A.
    Yamanaka, K.
    Koutoku, H.
    Kinoyama, I.
    Matsuhisa, A.
    Sasamata, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 122 - 122
  • [23] Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells
    Zhang, Shufeng
    Wang, Xiaohui
    Gu, Zhimin
    Wang, Li
    CANCER INVESTIGATION, 2016, 34 (08) : 401 - 407
  • [24] Formulation Design and Evaluation of Liposomal Sepantronium Bromide (YM155), a Small-Molecule Survivin Suppressant, Based on Pharmacokinetic Modeling and Simulation
    Kohsuke Shakushiro
    Hiroki Kawano
    Mari Nakata
    Aya Kita
    Atsushi Maeda
    Shunsuke Watanabe
    Kazuhiro Sako
    Naoto Oku
    Pharmaceutical Research, 2015, 32 : 238 - 247
  • [25] Formulation Design and Evaluation of Liposomal Sepantronium Bromide (YM155), a Small-Molecule Survivin Suppressant, Based on Pharmacokinetic Modeling and Simulation
    Shakushiro, Kohsuke
    Kawano, Hiroki
    Nakata, Mari
    Kita, Aya
    Maeda, Atsushi
    Watanabe, Shunsuke
    Sako, Kazuhiro
    Oku, Naoto
    PHARMACEUTICAL RESEARCH, 2015, 32 (01) : 238 - 247
  • [26] The Mechanism of Radiosensitization by YM155, a Novel Small Molecule Inhibitor of Survivin Expression, is Associated with DNA Damage Repair
    Hu, Songliu
    Fu, Songbin
    Xu, Xiangying
    Chen, Lin
    Xu, Jianyu
    Li, Bin
    Qu, Yuanyuan
    Yu, Hongyang
    Lu, Shan
    Li, Wenxin
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 37 (03) : 1219 - 1230
  • [27] Liquid chromatography-electrospray tandem mass spectrometric assay suitable for quantitation of YM155, a novel small-molecule survivin suppressant, in dog plasma
    Minematsu, Tsuyoshi
    Felder, Laurie
    Oppeneer, Todd
    Sakazume, Masashi
    Oikawa, Keishi
    Hashimoto, Tadashi
    Usui, Takashi
    Kamimura, Hidetaka
    BIOMEDICAL CHROMATOGRAPHY, 2008, 22 (07) : 763 - 769
  • [28] YM155, a Novel Small-Molecule Survivin Suppressant, Induces Regression of Established Human Hormone-Refractory Prostate Tumor Xenografts (vol 67, pg 8014, 2007)
    Nakahara, Takahito
    Kita, Aya
    Yamanaka, Kentaro
    Mori, Masamichi
    Amino, Nobuaki
    Takeuchi, Masahiro
    Tominaga, Fumiko
    Hatakeyama, Shinji
    Kinoyama, Isao
    Matsuhisa, Akira
    Kudou, Masafumi
    Sasamata, Masao
    CANCER RESEARCH, 2012, 72 (15) : 3886 - 3886
  • [29] A Small-Molecule Suppressant of Survivin YM155 Induces Cell Death Via Proteasomal Degradation of c-Myc in Multiple Myeloma Cells
    Ito, Shigeki
    Asahi, Maki
    Ishida, Yoji
    BLOOD, 2015, 126 (23)
  • [30] Synergistic Antitumor Activities of Sepantronium Bromide (YM155), a Survivin Suppressant, in Combination with Microtubule-Targeting Agents in Triple-Negative Breast Cancer Cells
    Kaneko, Naoki
    Yamanaka, Kentaro
    Kita, Aya
    Tabata, Kenji
    Akabane, Takafumi
    Mori, Masamichi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (12) : 1921 - 1927
12345